Solana Co

Solana Co(HSDT)股票分析

$2.090

-0.113 (-5.43%)收盤時

Loading chart…
High
2.210
Open
2.190
VWAP
2.12
Vol
309.79K
Mkt Cap
2.91M
Low
2.070
Amount
657.78K
EV/EBITDA, TTM
-0.92

Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.

AI analysis of Solana Co (HSDT)

buy

Helius Medical Technologies Inc (HSDT) is a good buy right now, trading at $2.34 with a recent RSI of 71.625 indicating strong momentum. The stock has shown a significant 41.82% increase over the past 20 days, suggesting positive short-term performance. Additionally, analysts project a price target of $3 to $4, indicating potential upside of 28.0% to 70.6%. However, the main risk is the company's negative earnings with a forward P/E of 0 and a recent quarterly loss of $0.05 per share, which could affect investor sentiment.

Analyst Ratings (1)

Buy
1 Buy
0 Hold
0 Sell
Current: 2.09
最低
平均
最高

B. Riley

2026-04-23

目標價

$3

Buy

Maxim Group

2024-10-16

目標價

Hold

Roth MKM

2024-03-05

目標價

$24

Strong Buy

Maxim Group

2022-12-20

目標價

$50

Strong Buy

Roth Capital

2022-08-23

目標價

$250

Strong Buy

估值指標

The current forward P/E ratio for Solana Co (HSDT) is 0.00, compared to its 5-year average forward P/E of -2.37.

Forward P/E

Fair
5Y Average P/E
-2.37
Current P/E
0.00
高估
4.26
低估
-9.01

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-0.90
Current EV/EBITDA
-0.92
高估
12.85
低估
-14.64

Forward P/S

Fair
5Y Average P/S
48.87
Current P/S
12.15
高估
224.89
低估
-127.14

Alphio AI Price Scenarios for HSDT

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%HSDT

$2.58

情境價格

B

Base

Base · 50%HSDT

$2.40

情境價格

B

Bear

Bear · 25%HSDT

$2.06

情境價格

Whales holding HSDT

V

VR Advisory Services Ltd.

+ HoldingHSDT

-2.20%

3M Return

事件時間軸

2026-06-30 (ET)

07:30:00

Solana Signs MoU with Alatau City for Blockchain Partnership

2026-06-16 (ET)

11:30:00

Hyperscale Data Plans to End Bitcoin Mining in Michigan

08:00:00

Solana Company Rejects Forward Industries Acquisition Proposal

2026-06-15 (ET)

09:30:00

Forward Industries Proposes All-Stock Merger to Solana

2026-04-27 (ET)

11:30:00

Bitcoin Climbs to $79,488 on Strong Institutional Demand

資訊

HSDT FAQ — answered by Alphio AI

Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders. It operates in the Financials sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).

Helius Medical Technologies Inc (HSDT) is a good buy right now, trading at $2.34 with a recent RSI of 71.625 indicating strong momentum. The stock has shown a significant 41.82% increase over the past 20 days, suggesting positive short-term performance. Additionally, analysts project a price target of $3 to $4, indicating potential upside of 28.0% to 70.6%. However, the main risk is the company's negative earnings with a forward P/E of 0 and a recent quarterly loss of $0.05 per share, which could affect investor sentiment.

1 analysts cover HSDT: 1 rate it Buy, 0 Hold and 0 Sell.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始